For product information:
For business and employment inquiries:
Growth is one of our primary goals at OraPharma. Along with professional and academic institutions, we endeavor to collaborate with oral healthcare companies to expand our offerings and services to our customers.
We are actively pursuing opportunities in licensing, co-promotion, research collaborations, and strategic alliances. For prospective partners, we offer a suite of unique capabilities:
Our company has established partnerships with leading academic institutions and professional associations to benefit dental students and professionals. The ARESTIN Student Access Program, for example, is committed to helping the next generation of professionals gain experience with our lead product, ARESTIN (minocycline HCl) Microspheres, 1 mg, as a part of comprehensive periodontal care. Since 2007, more than 10,000 dental students from more than 250 schools have participated in this program.
We are also engaged in a partnership with Datum Dental Ltd. for OSSIX PLUS and OSSIX VOLUMAX resorbable membranes as part of our growing product portfolio.
OSSIX is a trademark and/or registered trademark of Datum Biotech, Ltd., its subsidiaries, and/or affiliates in the United States and/or other countries.